Ethiopia vs Mauritania: Share of children with symptoms of a respiratory infection who received antibiotics
Ethiopia
27.6%
in 2018
Mauritania
23.0%
in 2018
Ethiopia rank
130th
Mauritania rank
132nd
Share of children with symptoms of a respiratory infection who received antibiotics over time
- Ethiopia
- Mauritania
How they compare
Ethiopia currently reports 27.6% against 23.0% in Mauritania, a difference of 4.6%.
That makes Ethiopia's figure about 1.2 times Mauritania's.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Ethiopia ahead.
Ethiopia ranks 130th and Mauritania ranks 132nd of 132 countries.
Across the 2 decades both report, Ethiopia averaged higher in 1 and Mauritania in 1.
Head to head by decade
| Decade | Ethiopia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.0% | 23.3% | 10.7% | Ethiopia |
| 2010s | 26.5% | 27.4% | 0.9% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, Ethiopia or Mauritania?
- Ethiopia, at 27.6% against 23.0% in Mauritania as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between Ethiopia and Mauritania?
- 4.6%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Mauritania?
- 19 years are reported by both, from 2000 to 2018.
- How do Ethiopia and Mauritania rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- Ethiopia ranks 130th and Mauritania ranks 132nd of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.